Summit Securities Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-3,000
Closed -$256K – 1131
2021
Q4
$256K Buy
+3,000
New +$234K 0.01% 537
2016
Q1
– Sell
-13
Closed -$19K – 171
2015
Q4
$19K Buy
+13
New +$865 0.01% 235

Other funds holding CL

Summit Securities Group's CL Position: Q3 2026 in Review

Summit Securities Group sold out of Colgate-Palmolive (CL) in Q3 2026, closing a stake of 186 shares — an estimated $17.1K sold.

Summit Securities Group first reported a position in CL in Q2 2013 and held it in 20 quarters. The position peaked at $5.27M in Q3 2013. 1,712 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Summit Securities Group reported no remaining Colgate-Palmolive position as of Q3 2026 after selling out during the quarter.
  • Summit Securities Group sold 186 Colgate-Palmolive shares in Q3 2026, an estimated $17.1K.
  • Summit Securities Group first reported a position in Colgate-Palmolive in Q2 2013 and held it in 20 quarters.
  • Summit Securities Group's Colgate-Palmolive position peaked at $5.27M in Q3 2013.
  • 1,712 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Summit Securities Group's 13F filing for Q3 2026, filed 5 Nov 2026.